RxDoctor Payments Data

Katherine Sandstrom, NP

Family · Portland, ORNPI 1982973095

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 37.0% of the total. Among family clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,117in general payments, 2019–2025

Across 223 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$799
  • Sanofi$550
  • E.r. Squibb & Sons, L.L.C.$530
  • Pfizer$437
  • Lilly USA, LLC$405
  • plus $501 from 11 others

What the payments were for

  • Food & beverage$4,76493%
  • Education$3537%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,117 in reported general payments places this provider in the 95th percentile of 1,130 family providers in Oregon.

See all family providers in Oregon

Medicare billing

Part B allowed, 2024
$60,575
Medicare patients
202
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab20$87,603
Tacrolimus54$4,255
Doxycycline Monohydrate90$3,439
Fluorouracil26$1,828
Clobetasol Propionate48$1,574
Ketoconazole61$1,145
Triamcinolone Acetonide66$1,016
Doxycycline Hyclate12$662
Clobetasol EmollientClobetasol Propionate/Emoll14$502
Spironolactone29$383
Mupirocin47$359
Minoxidil39$336
Hydrocortisone37$228

Paid to pharmacies, not to this prescriber.

Other family in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →